New Study to Address Cancer Treatment Resistance for People Who Are KRAS Positive

SAN CARLOS, Calif., Nov. 30, 2022 /PRNewswire/ -- The Addario Lung Cancer Medical Institute (ALCMI), a patient-founded not-for-profit global research consortium, has launched the SPARK Study to help researchers better understand treatment resistance in patients with KRAS-positive lung...

Click to view original post